Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
117 hedge funds and large institutions have $348M invested in Surmodics in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 6 closing their positions.
120% more call options, than puts
Call options by funds: $1.08M | Put options by funds: $490K
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
10% more capital invested
Capital invested by funds: $317M → $348M (+$30.8M)
3% more funds holding
Funds holding: 114 → 117 (+3)
0.79% more ownership
Funds ownership: 84.73% → 85.51% (+0.79%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$2.41M |
| 2 |
Millennium Management
New York
|
+$1.06M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$723K |
| 4 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$679K |
| 5 |
Renaissance Technologies
New York
|
+$612K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.92M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$956K |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$751K |
| 4 |
RA
Royce & Associates
New York
|
-$750K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$480K |
SRDX Hedge Fund Activity: Q3 2017 in Review
117 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2017, worth a combined $348M — up 9.7% from $317M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SRDX positions and 6 closed out — a net gain of 3 holders — while 35 added to existing stakes and 47 trimmed.
The largest buyer was Foundry Partners, opening a new position worth an estimated $2.41M. The largest seller was AQR Capital Management, cutting an estimated $1.92M.
- 117 institutional investors held Surmodics (SRDX) as of Q3 2017, up from 114 in Q2 2017.
- Funds reported $348M of Surmodics stock for Q3 2017, up 9.7% quarter-over-quarter.
- 9 funds opened new Surmodics positions in Q3 2017 and 6 closed out, a net change of +3 holders.
- The largest Surmodics buyer in Q3 2017 was Foundry Partners, an estimated $2.41M added.
- The largest Surmodics seller in Q3 2017 was AQR Capital Management, an estimated $1.92M sold.
Based on aggregated 13F filings for Q3 2017.